These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22267739)

  • 1. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.
    Alvin JW; Lacy DB
    J Struct Biol; 2017 Jun; 198(3):203-209. PubMed ID: 28433497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
    Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
    J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
    Egerer M; Giesemann T; Herrmann C; Aktories K
    J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
    Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
    Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a structural understanding of Clostridium difficile toxins A and B.
    Pruitt RN; Lacy DB
    Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural organization of the functional domains of Clostridium difficile toxins A and B.
    Pruitt RN; Chambers MG; Ng KK; Ohi MD; Lacy DB
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13467-72. PubMed ID: 20624955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
    Chen B; Liu Z; Perry K; Jin R
    Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
    D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
    BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
    Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutralizing antibody that blocks delivery of the enzymatic cargo of
    Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
    J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Paparella AS; Cahill SM; Aboulache BL; Schramm VL
    ACS Chem Biol; 2022 Sep; 17(9):2507-2518. PubMed ID: 36038138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.
    Egerer M; Giesemann T; Jank T; Satchell KJ; Aktories K
    J Biol Chem; 2007 Aug; 282(35):25314-21. PubMed ID: 17591770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.
    Darkoh C; Kaplan HB; Dupont HL
    J Clin Microbiol; 2011 Aug; 49(8):2933-41. PubMed ID: 21653766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TcdB of
    Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional defects in
    Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
    J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
    Li S; Shi L; Yang Z; Feng H
    Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.